All Stories

  1. Managing Small Airways Dysfunction in COPD Patients in Real Life Under Fixed Triple Combination of Beclomethasone/Formoterol/Glycopyrronium: The MASCOT Real World Evidence Study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2025, Taylor & Francis

    Chris Kyriakopoulos

  2. Interstitial Lung Abnormalities: Unraveling the Journey from Incidental Discovery to Clinical Significance

    Article • Diagnostics, February 2025, MDPI AG

    Chris Kyriakopoulos

  3. Oscillometry Assesses Small Airway Disease and Reveals Peripheral Lung Pathology in Early Pulmonary Fibrosis: A Cross-Sectional Study

    Article • Diagnostics, December 2024, MDPI AG

    Chris Kyriakopoulos

  4. Effectiveness of anti-IL-5/5Rα biologics in severe asthma in real-world studies: a systematic review and meta-analysis

    Article • ERJ Open Research, September 2024, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  5. Effect of Body Weight on Glycaemic Indices in People with Type 1 Diabetes Using Continuous Glucose Monitoring

    Article • Journal of Clinical Medicine, September 2024, MDPI AG

    Chris Kyriakopoulos

  6. Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials

    Article • European Respiratory Review, April 2024, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  7. Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality

    Article • Journal of Clinical Medicine, September 2023, MDPI AG

    Chris Kyriakopoulos

  8. Effects of Hypoglycemia on Cardiovascular Function in Patients with Diabetes

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Chris Kyriakopoulos

  9. Recurrent bilateral lung infiltrates in a patient with ulcerative colitis

    Article • Breathe, December 2022, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  10. Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study

    Article • Journal of Clinical Medicine, August 2022, MDPI AG

    Chris Kyriakopoulos

  11. Baseline characteristics and outcome predictors in patients hospitalized with COVID-19 in the University General Hospital of Ioannina, Greece

    Article • Pneumon, February 2022, E.U. European Publishing

    Chris Kyriakopoulos

  12. ICU admission and mortality classifiers for COVID-19 patients based on subgroups of dynamically associated profiles across multiple timepoints

    Article • Computers in Biology and Medicine, February 2022, Elsevier

    Chris Kyriakopoulos

  13. The Role of Digital Tools in the Timely Diagnosis and Prevention of Acute Exacerbations of COPD: A Comprehensive Review of the Literature

    Article • Diagnostics, January 2022, MDPI AG

    Chris Kyriakopoulos

  14. Evaluating the Impact of Triple Therapy on Mortality in Copd: The End is the Beginning?

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, January 2022, Taylor & Francis

    Chris Kyriakopoulos

  15. Reply

    Article • Respirology, January 2022, Wiley

    Chris Kyriakopoulos

  16. The Diagnostic Role of Uric Acid to Creatinine Ratio for the Identification of Patients with Adverse Pulmonary Embolism Outcomes

    Article • Diagnostics, January 2022, MDPI AG

    Dr Konstantinos Panagiotis Bartziokas, Chris Kyriakopoulos

  17. Microalbuminuria on admission for acute exacerbation of COPD as a predictor of all-cause mortality and future exacerbations

    Article • Postgraduate Medical Journal, December 2021, BMJ

    Chris Kyriakopoulos, Dr Konstantinos Panagiotis Bartziokas

  18. Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler® Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study

    Article • Journal of Personalized Medicine, November 2021, MDPI AG

    Chris Kyriakopoulos, Dr Konstantinos Panagiotis Bartziokas

  19. Tocilizumab administration for the treatment of hospitalized patients with COVID ‐19: A systematic review and meta‐analysis

    Article • Respirology, October 2021, Wiley

    Chris Kyriakopoulos

  20. Late Breaking Abstract - Tocilizumab administration for the treatment of hospitalised patients with COVID-19: A systematic review and meta-analysis

    Article • September 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  21. Biomarkers model for prediction of hospitalisation duration and pulmonary embolism outcome

    Article • September 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  22. Prothrombotic state in patients with stable COPD: an observational study

    Article • ERJ Open Research, August 2021, European Respiratory Society (ERS)

    Athanasios Konstantinidis, Chris Kyriakopoulos

  23. Hypercoagulable State in COPD-A Comprehensive Literature Review

    Article • Diagnostics, August 2021, MDPI AG

    Chris Kyriakopoulos

  24. Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study

    Article • BMC Pulmonary Medicine, July 2021, Springer Science + Business Media

    Chris Kyriakopoulos

  25. Achievement of High Quality Home Spirometry in Patients with Asthma: The NuvoAir Platform

    Article • May 2021, American Thoracic Society

    Chris Kyriakopoulos

  26. Reduction in Hospitalizations for Respiratory Diseases during the First COVID-19 Wave in Greece

    Article • Respiration, April 2021, Karger Publishers

    Chris Kyriakopoulos

  27. Endothelial injury in Chronic Obstructive Pulmonary Disease assessed by microalbuminuria (MAB) and von Willebrand factor levels and activity

    Article • March 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  28. The role of microalbuminuria (MAB) in patients admitted for an Acute COPD Exacerbation (AECOPD)

    Article • March 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  29. Hypercoagulability in patients with stable COPD assessed by coagulation factor levels

    Article • March 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  30. A 68-year-old man with haemoptysis and extensive ipsilateral lung infiltrates

    Article • Breathe, March 2021, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  31. Corticosteroids in COVID-19: one size does not fit all

    Article • European Respiratory Journal, February 2021, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas, Chris Kyriakopoulos

  32. A direct adverse effect of smoking

    Article • Respiratory Medicine Case Reports, January 2021, Elsevier

    Chris Kyriakopoulos

  33. Legionella pneumonia presenting with reverse halo sign

    Article • September 2020, Scientific Scholar

    Chris Kyriakopoulos

  34. Identification and treatment of T2-low asthma in the era of biologics

    Article • ERJ Open Research, September 2020, European Respiratory Society (ERS)

    Chris Kyriakopoulos, Dr. Konstantinos Kostikas, Dr Konstantinos Panagiotis Bartziokas

  35. Endothelial injury in COPD assessed by microalbuminuria (MAB) and von Willebrand factor levels (vWf:Ag) and activity (vWf:Ac)

    Article • September 2020, European Respiratory Society (ERS)

    christos Chronis , Chris Kyriakopoulos

  36. Hypercoagulability in patients with stable COPD assessed by coagulation factor levels

    Article • September 2020, European Respiratory Society (ERS)

    Chris Kyriakopoulos

  37. Primary Pulmonary Malignant Melanoma: Report of an Important Entity and Literature Review

    Article • Case Reports in Oncological Medicine, January 2017, Hindawi Publishing Corporation

    Professor Stergios Boussios, Chris Kyriakopoulos